About Us

CytoImage was established in 2020 by Associate Professor Tania Vu and Dr. Thomas Jacob from OHSU Knight Cancer Institute and the Dept. of Biomedical Engineering .  We are a seed stage company expediting the commercialization of a patented single cell functional precision medicine platform.  Our goal is to empower the expanding universe of cancer targets and accelerate the clinical development of the most promising combination therapies to extend  survival and escape disease relapse. 

Our Team

Meet the Team

Dan Snyder, MBA

CEO, Commercial Development

Tania Vu, PhD

CSO, Co-founder

Sandra Shotwell, PhD


Thomas Jacob, PhD

VP of R&D, Co-founder

Ann Bunnenberg, PhD, JD

Board Chair, Co-founder

Shula Jaron, PhD


People we trust

Partnerships and Collaborations


Partner with Us.

The CytoImage leadership team is actively looking for investment and commercial partners to accelerate the development of single cell functional precision medicine.